Download Whitepaper: Bayesian Methodologies to Address Clinical Development Challenges for COVID-19 Drugs, Devices and Biologics
The COVID-19 pandemic has elevated the challenge of designing and executing clinical trials within a substantially shortened time frame, and with limited data on the course of a newly emerged disease. The sense of urgency incites clinical researchers to invoke innovative trial design approaches to expedite the identification of efficacious interventions without compromising patient safety and scientific rigor. Bayesian statistical methods are very well suited to address these challenges due to their ability to adapt to knowledge that is gained during a trial.
Complete the form to download Cytel's latest whitepaper on this topic to learn more about Bayesian methods.